During the past decade, IPEPO - Instituto da visão conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "IPEPO - Instituto da visão" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator and "Pierre Fabre Medicament" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "IPEPO - Instituto da visão" are "Geographic Atrophy" (3 trials), "BRAF V600E-mutant Metastatic Colorectal Cancer" (1 trials), "Geographic Atrophy Secondary to Age-related Macular Degeneration" (1 trials), "Macular Degeneration" (1 trials) and "Neovascular Age-related Macular Degeneration (nAMD)" (1 trials). Many other conditions were trialed in "IPEPO - Instituto da visão" in a lesser frequency.

Most popular intervention types in "IPEPO - Instituto da visão" are "Drug" (4 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "No intervention" (2 trials), "5-Fluorouracil" (1 trials), "Binimetinib" (1 trials), "Cetuximab" (1 trials) and "Encorafenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "IPEPO - Instituto da visão" are 6 trials for "All" genders.

Currently, there are NaN active trials in "IPEPO - Instituto da visão". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in IPEPO - Instituto da visão, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in IPEPO - Instituto da visão, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".